English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Increased glutamine metabolism by macrophages is associated with development of atherosclerotic lesions. Positron emission tomography/computed tomography (PET/CT) with a glutamine analog (2S,4 R )-4- 18 F-fluoroglutamine ( 18 F-FGln) allows quantification of glutamine consumption  in vivo . Here, we investigated uptake of  18 F-FGln by atherosclerotic lesions in mice and compared the results with those obtained using the glucose analog 2-deoxy-2- 18 F-fluoro- D -glucose ( 18 F-FDG). Uptake of  18 F-FGln and  18 F-FDG by healthy control mice (C57BL/6JRj) and atherosclerotic low-density lipoprotein receptor-deficient mice expressing only apolipoprotein B100 (LDLR −/− ApoB 100/100 ) was investigated. The mice were injected intravenously with  18 F-FGln or  18 F-FDG for  in vivo  PET/CT imaging. After sacrifice at 70 minutes post-injection, tracer uptake was analyzed by gamma counting of excised tissues and by autoradiography of aorta cryosections, together with histological and immunohistochemical analyses. We found that myocardial uptake of  18 F-FGln was low. PET/CT detected lesions in the aortic arch, with a target-to-background ratio (SUV max , aortic arch/SUV mean , blood) of 1.95 ± 0.42 (mean ± standard deviation). Gamma counting revealed that aortic uptake of  18 F-FGln by LDLR −/− ApoB 100/100  mice (standardized uptake value [SUV], 0.35 ± 0.06) was significantly higher than that by healthy controls (0.20 ± 0.08,  P  = 0.03). More detailed analysis by autoradiography revealed that the plaque-to-healthy vessel wall ratio of  18 F-FGln (2.90 ± 0.42) was significantly higher than that of  18 F-FDG (1.93 ± 0.22,  P  = 0.004). Immunohistochemical staining confirmed that  18 F-FGln uptake in plaques co-localized with glutamine transporter SLC7A7-positive macrophages. Collectively these data show that the  18 F-FGln PET tracer detects inflamed atherosclerotic lesions. Thus, exploiting glutamine consumption using  18 F-FGln PET may have translational relevance for studying atherosclerotic inflammation.

Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2S,4R)-4-18F-Fluoroglutamine